Analysis Algernon Pharmaceuticals Inc. (AGNPF)
5/31/2024
Analysis of Algernon Pharmaceuticals Inc. (AGNPF)
Algernon Pharmaceuticals Inc. (AGNPF) has shown some interesting price movements and technical indicators in the recent days:1. Price Movement:
- The closing price has been fluctuating between 0.09000 and 0.11935 over the past week.
- The stock closed at 0.11020 on the most recent trading day, showing some upward momentum.
2. Technical Indicators:
- The Relative Strength Index (RSI) has been hovering around 60, indicating a neutral sentiment in the market.
- The Moving Average Convergence Divergence (MACD) indicator shows positive momentum with the MACD line above the signal line.
- The Moving Averages (SMA, EMA, WMA) are also showing an upward trend, suggesting a bullish sentiment.
3. Overall, Algernon Pharmaceuticals Inc. seems to be in a consolidation phase with some bullish signals in the technical indicators. Traders and investors may want to keep an eye on further price movements and key support/resistance levels for potential trading opportunities.
Earnings
The company's results for the most recent quarter, as of April 30, 2025, have not been provided at this time. The previous results from February 27, 2025, were handled by the Transfer Agent. The results from January 31, 2025, were released after hours. The results from October 31, 2024, were not provided at the time. The results from August 1, 2024, showed an earnings per share (EPS) estimate of 1.32.Main Statystic ðŸ§
The data provided includes financials, stock statistics, valuation metrics, stock price summary, and dividends and splits information for a specific company.In terms of financials, the company has strong operating cash flow and levered free cash flow, with a positive current ratio and a high total debt to equity ratio. The profit margin and operating margin are also healthy, indicating efficient operations. The company's fiscal year ends in September 2023, and the most recent quarter reported is March 2024. The company shows good returns on assets and equity.
In terms of stock statistics, there is a low short ratio and a significant percentage of shares held by institutions. The stock has a beta of 1.264 and has been trading within a range between a fifty-two-week low and high.
Valuation metrics show a relatively high PEG ratio and forward PE ratio. The company's market capitalization and enterprise value are substantial, with high price to book and price to sales ratios. The enterprise value to EBITDA and revenue ratios are also notable.
The stock price summary includes moving averages, fifty-two-week low and high prices, and the percentage change over the past year.
Dividends and splits information shows the company's dividend dates, payout ratios, and dividend yields, as well as details on past splits.
Income statement 💸
Here are the revenue figures for the company over the past four fiscal years:1. Fiscal Year 2023: Sales of $383,285,000,000
2. Fiscal Year 2022: Sales of $394,328,000,000
3. Fiscal Year 2021: Sales of $365,817,000,000
4. Fiscal Year 2020: Sales of $274,515,000,000
From these figures, we can observe the following trends:
- The company experienced a decrease in revenue from FY 2022 to FY 2023.
- Prior to FY 2023, there was a general trend of increasing revenue over the years.
- The highest revenue was recorded in FY 2022.
These trends can provide insights into the company's performance and may indicate areas that require further analysis or attention.
Balance Sheet
These are balance sheets. Here are the conclusions:1. The total assets have been increasing over the years, reaching $365,725,000,000 in 2018.
2. Current assets have fluctuated, with the highest value in 2019 at $162,819,000,000.
3. Non-current assets have shown an increasing trend, with the highest value in 2019 at $175,697,000,000.
4. Total liabilities have also been increasing, reaching $290,437,000,000 in 2023.
5. Shareholders' equity has shown fluctuations but has generally been increasing, with the highest value in 2018 at $107,147,000,000.
Cash Flow 💶
This is a cash flow statement. Here are some conclusions we can draw from the data:1. The company's free cash flow has been fluctuating over the years, with the highest value in 2022 and the lowest in 2020.
2. Operating cash flow has generally been increasing, indicating improved operational efficiency.
3. The company has been consistently paying interest and income taxes, with varying amounts each year.
4. The end cash position has also been fluctuating, reaching its highest value in 2020.
5. Financing activities show significant variations, with large amounts being spent on common stock repurchase and debt issuance.
6. Investing activities also vary, with notable amounts spent on the sale and purchase of investments.
7. Overall, the company's financial activities seem to be dynamic, with different strategies being employed each year to manage cash flow and investments.
Earnings estimate
Based on analysts' estimates for future quarterly and annual earnings per share:1. For the current quarter ending on June 30, 2024, the average estimated EPS is $1.33, with a range from $1.27 to $1.36. This shows growth compared to the EPS of $1.26 from a year ago.
2. For the next quarter ending on September 30, 2024, the average estimated EPS is $1.53, with a range from $1.44 to $1.63. This indicates an increase compared to the EPS of $1.46 from a year ago.
3. For the current year ending on September 30, 2024, the average estimated EPS is $6.59, with a range from $6.43 to $6.92. This reflects growth compared to the EPS of $6.13 from the previous year.
4. For the next year ending on September 30, 2025, the average estimated EPS is $7.23, with a range from $6.40 to $7.90. This suggests an increase compared to the EPS of $6.59 from the current year.
Overall, the analysts' estimates indicate a positive outlook for the company's earnings per share, with expected growth in both the short term and the long term.
Revenue estimate
Based on the analysts' estimates for the future quarterly and annual sales of the company, we can draw the following conclusions:1. For the current quarter ending on June 30, 2024, the average sales estimate is $83,776,900,000, with a sales growth of 2% compared to the same quarter last year. The number of analysts providing estimates is 24.
2. For the next quarter ending on September 30, 2024, the average sales estimate is $92,375,300,000, with a sales growth of 3% compared to the same quarter last year. The number of analysts providing estimates is 24.
3. For the current fiscal year ending on September 30, 2024, the average sales estimate is $386,681,000,000, with a sales growth of 1% compared to the previous fiscal year. The number of analysts providing estimates is 37.
4. For the next fiscal year ending on September 30, 2025, the average sales estimate is $411,555,000,000, with a sales growth of 6% compared to the current fiscal year. The number of analysts providing estimates is 37.
These estimates suggest a moderate growth trend in both quarterly and annual sales for the company over the specified periods.
Growth estimates
Based on the consensus estimates provided:- The company is expected to experience a growth rate of 7.5% in the current year and 9.7% in the next year.
- For the current quarter, the growth rate is estimated to be 5.6%, while for the next quarter it is projected to be 4.8%.
- Over the next 5 years, the company is expected to achieve an average annual growth rate of 11%.
- However, when looking at the past 5 years, the company has achieved a higher average annual growth rate of approximately 20.1%.
Overall, the company is expected to maintain a positive growth trajectory, with a slightly higher growth rate projected for the next 5 years compared to the current and upcoming quarters.
Price target
The analysts' forecast for the future price of the security paper is as follows:- Low: $164
- High: $250
- Median: $200
- Average: $202.26
- Current price: $191.57
- Currency: USD
Based on these forecasts, we can see that the analysts have a range of opinions on the future price of the security paper, with the low end at $164, the high end at $250, and the average at $202.26. The current price is below both the average and median forecast, indicating a potential opportunity for growth according to the analysts' predictions.
MACD of AGNPF
This is not investment advice. Remember to verify the information provided here.
Get access to the full analysis
- Over 35 000 indexes
- CFD, Forex, Crypto and Stocks Exchange
- Over 150 Indicators
- Pattern and candle analysis
- Support and resistance levels
- Fundamental, technical and sentimental analysis
- Power from AI
